A mass cytometry-based lens on DNA damage repair in circulating tumor cells from breast cancer patients
- PMID: 40879317
- DOI: 10.1002/ijc.70105
A mass cytometry-based lens on DNA damage repair in circulating tumor cells from breast cancer patients
References
REFERENCES
-
- Bidard FC, Peeters DJ, Fehm T, et al. Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data. Lancet Oncol. 2014;15(4):406‐414.
-
- Thomas‐Bonafos T, Pierga JY, Bidard FC, Cabel L, Kiavue N. Circulating tumor cells in breast cancer: clinical validity and utility. NPJ Breast Cancer. 2024;10(1):103.
-
- Hu Z, Li Z, Ma Z, Curtis C. Multi‐cancer analysis of clonality and the timing of systemic spread in paired primary tumors and metastases. Nat Genet. 2020;52(7):701‐708.
-
- Bortolini Silveira A, Bidard FC, Tanguy ML, et al. Multimodal liquid biopsy for early monitoring and outcome prediction of chemotherapy in metastatic breast cancer. NPJ Breast Cancer. 2021;7(1):115.
-
- Radovich M, Jiang G, Hancock BA, et al. Association of circulating tumor DNA and circulating tumor cells after neoadjuvant chemotherapy with disease recurrence in patients with triple‐negative breast cancer: preplanned secondary analysis of the BRE12‐158 randomized clinical trial. JAMA Oncol. 2020;6(9):1410‐1415.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources